Els O. Witteveen
- Oncology top 5%
- Molecular Biology
- Reproductive Medicine top 5%
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Emile E. VoestMarlies H.G. LangenbergJeanine M.L. RoodhartPeter M. HeintzFlora VernooijYolanda van der GraafJan H.M. SchellensJos H. Beijnen
- Topics
- Cancer Treatment and Pharmacology (9 papers)Cancer therapeutics and mechanisms (5 papers)Cancer, Hypoxia, and Metabolism (4 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Els O. Witteveen
22 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 87
- Oncology 536
- Molecular Biology 434
- Reproductive Medicine 204
- Cancer Research 178
- Pulmonary and Respiratory Medicine 158
Countries citing papers authored by Els O. Witteveen
This map shows the geographic impact of Els O. Witteveen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Els O. Witteveen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Els O. Witteveen more than expected).
Fields of papers citing papers by Els O. Witteveen
This network shows the impact of papers produced by Els O. Witteveen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Els O. Witteveen. The network helps show where Els O. Witteveen may publish in the future.
Co-authorship network of co-authors of Els O. Witteveen
This figure shows the co-authorship network connecting the top 25 collaborators of Els O. Witteveen. A scholar is included among the top collaborators of Els O. Witteveen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Els O. Witteveen. Els O. Witteveen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 3 | |
| 3 | 35 | |
| 4 | 15 | |
| 5 | 81 | |
| 6 | 63 | |
| 7 | 171 | |
| 8 | 32 | |
| 9 | 191 | |
| 10 | 89 | |
| 11 | 23 | |
| 12 | 1 | |
| 13 | 9 | |
| 14 | 7 | |
| 15 | 107 | |
| 16 | 7 | |
| 17 | 2 | |
| 18 | 1 | |
| 19 | Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study. | 51 |
| 20 | Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid. | 29 |
About Els O. Witteveen
Els O. Witteveen is a scholar working on Oncology, Reproductive Medicine and Cancer Research, having authored 23 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Cancer therapeutics and mechanisms (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Reproductive Medicine (204 citations), Obstetrics and Gynecology (155 citations) and Oncology (536 citations). Els O. Witteveen has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Emile E. Voest, Marlies H.G. Langenberg, Jeanine M.L. Roodhart, Peter M. Heintz, Flora Vernooij, Yolanda van der Graaf, Jan H.M. Schellens, Jos H. Beijnen, Sandra A. Radema and Laurens V. Beerepoot. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.